The Fear of Regaining Weight on GLP-1: Talking About Long-Term Care

For some people, successful weight loss comes with a new worry: "What happens if I stop?" That fear makes sense when treatment feels helpful and online conversations focus on regain. But your future isn't predetermined. An honest long-term plan is more useful than either a promise that weight will never return or an assumption that regain is inevitable for everyone.

What withdrawal research found

The most-cited example is the STEP 1 trial extension. It followed 327 participants at selected sites (228 who had taken semaglutide 2.4 mg and 99 placebo) for a year after both the medicine and the trial's lifestyle program stopped. The semaglutide group had lost an average of 17.3% of their starting weight; over the following year they regained an average of 11.6 percentage points, about two-thirds of what they had lost, leaving them 5.6% below baseline at week 120. Results varied a lot between individuals, and about 48% still kept at least 5% off.

A 2026 BMJ systematic review pooled 37 studies (9,341 participants) of different weight-management medicines, including but not limited to GLP-1 drugs. After treatment ended, weight came back at an average of about 0.4 kg per month, faster than after behavioral weight programs, and improvements in cardiometabolic markers (measures linked to heart and metabolic health) were projected to return to baseline within about 1.4 years. The authors suggested caution about short-term use without a broader long-term plan.

Together, these studies show that regain is common after stopping. They don't predict the exact outcome for any one person, and they don't apply equally to every medicine or situation. (For a closer look at the STEP 1 data, see what happens when you stop semaglutide.)

Why this is not a willpower story

Obesity is a chronic, complex condition, and the body's appetite and energy regulation can push back after weight loss. That's biology, not a character flaw. Some people need long-term treatment; others follow a different plan because of side effects, other health risks, personal goals or access. The right approach depends on your health and current evidence—not on a simple rule that medication should always be temporary, or always continue forever. Our piece on obesity as a chronic disease explores this more.

Talk about the plan before a crisis

Ask your prescriber what long-term treatment might look like, what to expect if treatment changes, how follow-up will work and what options exist if cost or side effects become difficult. If you might need to stop, don't taper or restart on your own—ask for product-specific guidance and a plan for monitoring afterward.

Protect your mental space

Try not to turn every meal, weigh-in or body change into a test of whether you'll "keep the weight off." Day-to-day scale changes are normal, and trends over weeks are more meaningful. If fear becomes overwhelming, or leads to severe restriction, constant weighing or distress, consider talking with a healthcare professional or therapist.

The best plan includes a realistic conversation about maintenance, support and uncertainty. It should help you feel prepared, not trapped by a frightening prediction.